Back

TRIB1 as a novel therapeutic target in endothelial dysfunction

17 April 2026 (13:20 - 14:20)
Organised by: Logo
Congress Presentation Part of: Vascular dysfunction in vascular disease Biomarkers Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Mrs Valeria Prete

University of Salerno, Baronissi (Italy)

4 More presentations in this session

Presentation thumbnail
AQP1 drives endothelial dysfunction through extracellular hydrogen peroxide transport
Professor V. Montiel (Brussels, BE)
Abstract
Presentation thumbnail
Endothelial Prdm16 limits infarct growth by maintaining cerebrovascular function during ischaemic stroke
Doctor H. Kemps (Leuven, BE)
Abstract
Presentation thumbnail
Recharging the aorta: targeting endothelial dysfunction and bioenergetics in Loeys-Dietz syndrome
Miss R. Knapczyk (Gdansk, PL)
Abstract
Presentation thumbnail
The role of endothelial PRDM16 in a mouse model of experimental pulmonary arterial hypertension
Ms A. Mahy (Leuven, BE)
Abstract

Access the full session

Session thumbnail
Vascular dysfunction in vascular disease

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April 2026 13:20 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
Predictors of 1-year follow-up period MACE in patients with NSTEMI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources